Allergan rejects Valeant and Ackman’s raised takeover offer

(Reuters) – The battle for botox maker Allergan Inc heated up on Tuesday as the company officially rejected a sweetened $53 billion takeover offer from Valeant Pharmaceuticals International and activist investor William Ackman.

Link to article:


Leave a Reply

Your email address will not be published. Required fields are marked *